US Patent Issued to Takeda Pharmaceutical on Sept. 30 for "N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,403, issued on Sept. 30, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists" was invented by Zacharia Cheruvallath (San Diego), Jason Green (San Diego), Kristin Schleicher (San Diego), Huikai Sun (San Diego) and Mingnam Tang (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula (1), and pharmaceutically acceptable salts thereof, wherein n, R1, R4, R5, R6, R7, R8, R9, R10, R11, R14, X2, X3 and X12 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds...